NSETrading Window28 Sept 2026 · 28 Sept 2026, 05:26 pm

Trading Window

Epigral Limited · EPIGRAL

✦ AI Summary

Epigral Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.

Analysis Scores

Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Epigral Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Attachments (1)

📄

MFL_28092026172629_Epigral_-Trading_Window_Closure_Intimation.pdf

pdf

Download →
View document text
28.09.2026 National Stock Exchange of India Limited BSE Limited “Exchange Plaza”, Floor- 25, P J Tower, Bandra-Kurla Complex, Dalal Street, Bandra (East), Mumbai 400 051 Mumbai 400 001 SYMBOL:- EPIGRAL Scrip Code:- 543332 Dear Sirs, Sub.: Notice of Closure of Trading Window In terms of the applicable provisions of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 as amended and trading restrictions placed by the Company's Code of Practices, Procedure and Conduct to Regulate, Monitor and Report Trading by Insiders (‘the Code’), we hereby inform that the Trading Window for purchasing / selling or dealing in the Equity Shares of the Company, will remain closed for all Insiders, Directors, Promoters, Designated Persons and their Immediate Relatives from Thursday, 1st October, 2026 till the expiry of 48 hours after the declaration of the Un-Audited Financial Results for the Second Quarter and Half Year ended 30th September, 2026. We further inform that the Company has designated ‘Central Depository Service Limited’ for restricting trading by Designated Person(s) and their Immediate Relatives by freezing PAN at security level only for Company’s ISIN - INE071N01016 in accordance with SEBI Circular SEBI/HO/ISD/ISD-PoD-2/P/ CIR/2023/124 dated 19th July, 2023 and Circular SEBI/HO/ISD/ ISD-PoD-2/P/CIR/2025/55 dated 21st April 2025. The date of the Board Meeting for approval of the Un-Audited Financial Results for the Second Quarter and Half Year ended 30th September, 2026, will be announced in due course. You are requested to kindly take the same on your record. Thanking you, Yours faithfully, For Epigral Limited Gaurang Trivedi Company Secretary & Compliance Officer M. No. A22307